Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine

Vaccine

Volumn 17, Issue 5, 1999, Pages 454-458

  Larsson, Charlotte ^a   Stålhammar Carlemalm, Margaretha ^a   Lindahl, Gunnar ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Bivalent; Group B streptococcus; Protein vaccine

Indexed keywords

ALUMINUM HYDROXIDE; BACTERIAL ANTIGEN; STREPTOCOCCUS VACCINE;

ADOLESCENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; DRUG EFFICACY; EXPERIMENTAL INFECTION; IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; IMMUNIZATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C3H; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0345222513     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00218-7     Document Type: Article

References (19)

1. Baker C., Edwards M.S. Group B streptococcal infections. In: Remington J.S., Klein J.O., editors. Infectious Diseases of the Fetus and Newborn Infant, 2nd edn. Philadelphia: WB Saunders Co, 1995. p. 980-1054.
2. Farley M.M., Harvey R.C., Stull T., Smith J.D., Schuchat A., Wenger J.D., Stephens D.S. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med. 328:1993;1807-1811.
3. Baker C.J. Immunization to prevent group B streptococcal disease: victories and vexations. J Infect Dis. 161:1990;917-921.
4. Mohle-Boetani J.C., Schuchat A., Plikaytis B.D., Smith J.D., Broome C.V. Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis. JAMA. 270:1993;1442-1448.
5. Kogan G., Uhrin D., Brisson J.R., Paoletti L.C., Blodgett A.E., Kasper D.L., Jennings H.J. Structural and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide. J Biol Chem. 271:1996;8786-8790.
6. Lagergård T., Shiloach J., Robbins J.B., Schneerson R. Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid. Infect Immun. 58:1990;687-694.
7. Paoletti L.C., Wessels M.R., Rodewald A.K., Shroff A.A., Jennings H.J., Kasper D.L. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun. 62:1994;3236-3243.
8. Bevanger L., Naess A.I. Mouse-protective antibodies against the Ibc proteins of group B streptococci. Acta Pathol Microbiol Immunol Scand B. 93:1985;121-124.
9. Stålhammar-Carlemalm M., Stenberg L., Lindahl G. Protein Rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J Exp Med. 177:1993;1593-1603.
10. Madoff L.C., Michel J.L., Gong E.W., Rodewald A.K., Kasper D.L. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein. Infect Immun. 60:1992;4989-4994.
11. Larsson C., Stålhammar-Carlemalm M., Lindahl G. Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and α Infect Immun. 64:1996;3518-3523.
12. Michel J.L., Madoff L.C., Olson K., Kling D.E., Kasper D.L., Ausubel F.M. Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. Proc Natl Acad Sci USA. 89:1992;10060-10064.
13. Wästfelt M., Stålhammar-Carlemalm M., Delisse A.-M., Cabezon T., Lindahl G. Identification of a family of streptococcal surface proteins with extremely repetitive structure. J Biol Chem. 271:1996;18892-18897.
14. Cox J.C., Coulter A.R. Adjuvants: a classification and review of their modes of action. Vaccine. 15:1997;248-256.
15. van Zutphen L.F.M., Baumans V., Beynen A.C., editors. Principles of laboratory animal science. A contribution to the human use and care of animals and to the quality of experimental results. Amsterdam, Elseviers Science B.V., 1993.
16. Blumberg H.M., Stephens D.S., Modansky M., Erwin M., Elliot J., Facklam R.R., Schuchat A., Baughman W., Farley M.M. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis. 173:1996;365-373.
17. Lachenauer C.S., Madoff L.C. A protective surface protein from type V group B streptococci shares N-terminal sequence homology with the alpha C protein. Infect Immun. 64:1996;4255-4260.
18. Briles D.E., King J.D., Gray M.A., McDaniel L.S., Swiatlo E., Benton K.A. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine. 14:1996;858-867.
19. Martin D., Cadieux N., Hamel J., Brodeur B.R. Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection. J Exp Med. 185:1997;1173-1183.